Screener
Aquestive Therapeutics, Inc. AQST Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Aquestive Therapeutics, Inc.’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:10 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001398733-26-000042
FAQ
- What is Aquestive Therapeutics, Inc.'s total equity?
- Aquestive Therapeutics, Inc. (AQST) reported total equity of -$56.59M in Q2 2026.
- How has Aquestive Therapeutics, Inc.'s total equity changed year-over-year?
- Aquestive Therapeutics, Inc.'s total equity increased by 22.0% year-over-year, from -$72.59M to -$56.59M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s total equity?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s total equity has grown at a -7.0% compound annual growth rate (CAGR), from -$48.5M to -$33.66M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Aquestive Therapeutics, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude